v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 24,365 $ 25,312
Short-term investments 3,756 3,801
Accounts receivable, net of allowances of $1,208 and $985 23,018 22,365
Other current receivables, net of allowances of $3,763 and $2,864 29,697 26,089
Prepaid expenses and other current assets 9,746 8,212
Total current assets 90,582 85,779
Long-term investments 54,251 52,354
Property, equipment and capitalized software, net of accumulated depreciation and amortization of $7,546 and $6,971 10,762 10,553
Goodwill 110,499 106,734
Other intangible assets, net of accumulated amortization of $7,472 and $8,350 20,474 23,268
Other assets 23,013 19,590
Total assets 309,581 298,278
Current liabilities:    
Medical costs payable 39,337 34,224
Accounts payable and accrued liabilities 38,032 34,337
Short-term borrowings and current maturities of long-term debt 6,069 4,545
Unearned revenues 3,413 3,317
Other current liabilities 28,046 27,346
Total current liabilities 114,897 103,769
Long-term debt, less current maturities 72,320 72,359
Deferred income taxes 2,421 3,620
Other liabilities 18,245 15,939
Total liabilities 207,883 195,687
Commitments and contingencies (Note 12)
Redeemable noncontrolling interests 1,608 4,323
Equity:    
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0
Common stock, $0.01 par value - 3,000 shares authorized; 906 and 915 issued and outstanding 9 9
Additional paid-in capital 559 0
Retained earnings 95,603 96,036
Accumulated other comprehensive loss (2,061) (3,387)
Nonredeemable noncontrolling interests 5,980 5,610
Total equity 100,090 98,268
Total liabilities and shareholders’ equity $ 309,581 $ 298,278